Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- GSK announces positive headline results from the pivotal DREAMM-2 study for multiple myeloma
- ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months
- GSK submits first regulatory application for daprodustat in Japan for patients with renal anaemia due to chronic kidney disease
Tweets from GSK
-
GSK @GSK
Jilcia is a biopharmaceutical investigator at our Rockville manufacturing site where she plays an important role in bringing new medicines for people living with multiple myeloma to market. Go #BehindTheScience to find out how: gsk.to/2IipFkZ #FacesOfGSK
about 22 hours ago
-
GSK @GSK
Mosquito-borne diseases are still prevalent in 2019. That’s why we’re using our science to fight malaria, including developing the world’s first #malariavaccine for young children in Africa #WorldMosquitoDay twitter.com/GaviSeth/statu…
about 3 days ago
-
GSK @GSK
We're delighted to welcome professional racing driver @GoCharlieM to GSK, to share her inspirational story of life as a transgender woman in international motorsport. #LGBTQ twitter.com/GoCharlieM/sta…
about 3 days ago
